GFM
CRBU icon

GF Fund Management’s Caribou Biosciences CRBU Stock Holding History

GF Fund Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43K Sell
1,951
-148
-7% -$293 ﹤0.01% 583
2026
Q1 		$3.99K Buy
2,099
+264
+14% +$453 ﹤0.01% 611
2025
Q4 		$2.92K Buy
+1,835
New +$3.85K ﹤0.01% 637

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GF Fund Management's CRBU Position: Q2 2026 in Review

GF Fund Management reduced its Caribou Biosciences (CRBU) stake by 7.1% in Q2 2026, selling an estimated $293 and leaving 1,951 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

GF Fund Management first reported a position in CRBU in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.99K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • GF Fund Management held 1,951 shares of Caribou Biosciences worth $3.43K as of Q2 2026.
  • GF Fund Management sold 148 Caribou Biosciences shares in Q2 2026, an estimated $293.
  • Caribou Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #583 holding.
  • GF Fund Management first reported a position in Caribou Biosciences in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's Caribou Biosciences position peaked at $3.99K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.